Roles of microRNA-539 and osteopontin in rheumatoid arthritis

Liu,Yan; Qian,Kai; Li,Chunmei; Ma,Yi; Chen,Xingguo

doi:10.3892/etm.2017.5665

Roles of microRNA-539 and osteopontin in rheumatoid arthritis

Authors:
- Yan Liu
- Kai Qian
- Chunmei Li
- Yi Ma
- Xingguo Chen
View Affiliations

Affiliations: Department of Rheumatology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu 223300, P.R. China, Department of Rheumatology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210006, P.R. China
Published online on: December 21, 2017 https://doi.org/10.3892/etm.2017.5665
Pages: 2681-2687

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the role and mechanism of microRNA-539 (miR-539) in rheumatoid arthritis (RA). A total of 68 RA patients and 46 osteoarthritis patients were enrolled into the current study. Peripheral blood and joint fluid were collected prior to treatment. Reverse transcription‑quantitative polymerase chain reaction was performed to detect osteopontin (OPN) mRNA and miR‑539 expression levels, while ELISA and western blot analysis were applied to detect OPN protein expression. In addition, bioinformatics analysis predicted that miR‑539 directly targeted OPN, while dual‑luciferase assay was used to validate this finding. Furthermore, agomiR‑539 transfection and OPN knockdown by siRNA were conducted in MH7A cells, and MTT assay was used to detect MH7A cell proliferation. The results indicated that OPN was significantly increased in the blood and joint fluid of RA patients, while miR‑539 expression was significantly decreased in the two types of specimens (P<0.05). Subsequent to silencing OPN by siRNA, the proliferation of MH7A cells was decreased (P<0.05). Following upregulation of miR‑539, OPN expression was significantly decreased and cell proliferation was inhibited. Dual‑luciferase assay revealed that miR‑539 regulated OPN expression through complementary binding to 3'‑untranslated region. OPN was also significantly increased in the blood and joint fluid of RA patients, which may be associated with the downregulation of miR‑539. Thus, miR‑539 may promote the development and progression of RA through regulating OPN.

View Figures

View References

1	Goodman SM and Figgie MA: Arthroplasty in patients with established rheumatoid arthritis (RA): Mitigating risks and optimizing outcomes. Best Pract Res Clin Rheumatol. 29:628–642. 2015. View Article : Google Scholar : PubMed/NCBI
2	Canadian Agency for Drugs and Technologies in Health, . Biologic Switching for Patients with Rheumatoid Arthritis: A Review of Clinical Effectiveness, Safety, and GuidelinesRapid Response Reports: Summary with Critical Appraisal. Canadian Agency for Drugs and Technologies in Health; Ottawa, ON: 2015
3	Sandoo A, Veldhuijzen van Zanten JJ, Metsios GS, Carroll D and Kitas GD: Vascular function and morphology in rheumatoid arthritis: A systematic review. Rheumatology (Oxford). 50:2125–2139. 2011. View Article : Google Scholar : PubMed/NCBI
4	Lu Z and Zhong N: Internal medicine. People's Medical Publishing House; Beijing: 2008, View Article : Google Scholar
5	Holmdahl R: The Hereditary Basis of Rheumatic Diseases. Birkhäuser Basel; Basel: 2006, View Article : Google Scholar
6	Churov AV, Oleinik EK and Knip M: MicroRNAs in rheumatoid arthritis: Altered expression and diagnostic potential. Autoimmun Rev. 14:1029–1037. 2015. View Article : Google Scholar : PubMed/NCBI
7	Chen XM, Huang QC, Yang SL, Chu YL, Yan YH, Han L, Huang Y and Huang RY: Role of micro RNAs in the pathogenesis of rheumatoid arthritis: Novel perspectives based on review of the literature. Medicine (Baltimore). 94:e13262015. View Article : Google Scholar : PubMed/NCBI
8	Murata K, Yoshitomi H, Furu M, Ishikawa M, Shibuya H, Ito H and Matsuda S: MicroRNA-451 down-regulates neutrophil chemotaxis via p38 MAPK. Arthritis Rheumatol. 66:549–559. 2014. View Article : Google Scholar : PubMed/NCBI
9	Jeanson-Leh L, Lameth J, Krimi S, Buisset J, Amor F, Le Guiner C, Barthélémy I, Servais L, Blot S, Voit T and Israeli D: Serum profiling identifies novel muscle miRNA and cardiomyopathy-related miRNA biomarkers in golden retriever muscular dystrophy dogs and duchenne muscular dystrophy patients. Am J Pathol. 184:2885–2898. 2014. View Article : Google Scholar : PubMed/NCBI
10	Chen YP, Jin X, Xiang Z, Chen SH and Li YM: Circulating MicroRNAs as potential biomarkers for alcoholic steatohepatitis. Liver Int. 33:1257–1265. 2013. View Article : Google Scholar : PubMed/NCBI
11	Hu H, Zhang Y, Cai XH, Huang JF and Cai L: Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts. Oncol Lett. 4:1037–1042. 2012. View Article : Google Scholar : PubMed/NCBI
12	Xu SF, Zhao FT, Zhao H, Wang YL and Liu QF: Study of Effects of Direct Intra-articular Injection of Adenovirus-Fasl on Apoptosis of Synoviocytes in Adjuvant Arthritis Rats. Medical Recapitulate. 18:443–445. 2012.
13	Chen G, Zhang X, Li R, Fang L, Niu X, Zheng Y, He D, Xu R and Zhang JZ: Role of osteopontin in synovial Th17 differentiation in rheumatoid arthritis. Arthritis Rheum. 62:2900–2908. 2010. View Article : Google Scholar : PubMed/NCBI
14	Attur MG, Dave MN, Stuchin S, Kowalski AJ, Steiner G, Abramson SB, Denhardt DT and Amin AR: Osteopontin: An intrinsic inhibitor of inflammation in cartilage. Arthritis Rheum. 44:578–584. 2001. View Article : Google Scholar : PubMed/NCBI
15	Honsawek S, Tanavalee A, Sakdinakiattikoon M, Chayanupatkul M and Yuktanandana P: Correlation of plasma and synovial fluid osteopontin with disease severity in knee osteoarthritis. Clin Biochem. 42:808–812. 2009. View Article : Google Scholar : PubMed/NCBI
16	Kim KJ, Kwak J, Lee JH and Lee SS: Real-time qRT-PCR assay for the detection of miRNAs using bi-directional extension sequences. Anal Biochem. 536:32–35. 2017. View Article : Google Scholar : PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Chieng LO, Madhavan K and Vanni S: Pooled data analysis on anterior versus posterior approach for rheumatoid arthritis at the craniovertebral junction. Neurosurg Focus. 38:E182015. View Article : Google Scholar : PubMed/NCBI
19	Caplazi P, Baca M, Barck K, Carano RA, DeVoss J, Lee WP, Bolon B and Diehl L: Mouse models of rheumatoid arthritis. Vet Pathol. 52:819–826. 2015. View Article : Google Scholar : PubMed/NCBI
20	Olumuyiwa-Akeredolu OO and Pretorius E: Platelet and red blood cell interactions and their role in rheumatoid arthritis. Rheumatol Int. 35:1955–1964. 2015. View Article : Google Scholar : PubMed/NCBI
21	Kerola AM, Kauppi MJ, Nieminen T, Rantalaiho V, Kautiainen H, Kerola T, Virta LJ, Pohjolainen T and Puolakka K: Psychiatric and cardiovascular comorbidities as causes of long-term work disability among individuals with recent-onset rheumatoid arthritis. Scand J Rheumatol. 44:87–92. 2015. View Article : Google Scholar : PubMed/NCBI
22	Lin Y and Yang-Yen HF: The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. J Biol Chem. 276:46024–46030. 2001. View Article : Google Scholar : PubMed/NCBI
23	Wang KX and Denhardt DT: Osteopontin: Role in immune regulation and stress responses. Cytokine Growth Factor Rev. 19:333–345. 2008. View Article : Google Scholar : PubMed/NCBI
24	Gattorno M, Gregorio A, Ferlito F, Gerloni V, Parafioriti A, Felici E, Sala E, Gambini C, Picco P and Martini A: Synovial expression of osteopontin correlates with angiogenesis in juvenile idiopathic arthritis. Rheumatology (Oxford). 43:1091–1096. 2004. View Article : Google Scholar : PubMed/NCBI
25	Gao SG, Li KH, Zeng KB, Tu M, Xu M and Lei GH: Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients. Osteoarthritis Cartilage. 18:82–87. 2010. View Article : Google Scholar : PubMed/NCBI
26	Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, Nifuji A, Uede T, Denhardt DT and Noda M: Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc Natl Acad Sci USA. 99:pp. 4556–4561. 2002; View Article : Google Scholar : PubMed/NCBI
27	Petrow PK, Hummel KM, Schedel J, Franz JK, Klein CL, Müller-Ladner U, Kriegsmann J, Chang PL, Prince CW, Gay RE and Gay S: Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: Effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts. Arthritis Rheum. 43:1597–1605. 2000. View Article : Google Scholar : PubMed/NCBI
28	Liu K, Liu S, Zhang W, Jia B, Tan L, Jin Z and Liu Y: miR-494 promotes cell proliferation, migration and invasion and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN. Oncol Rep. 34:1003–1010. 2015. View Article : Google Scholar : PubMed/NCBI
29	Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15–20. 2005. View Article : Google Scholar : PubMed/NCBI
30	Chen K and Rajewsky N: The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet. 8:93–103. 2007. View Article : Google Scholar : PubMed/NCBI